CN112973986B - a centrifugal device - Google Patents
a centrifugal device Download PDFInfo
- Publication number
- CN112973986B CN112973986B CN201911286626.2A CN201911286626A CN112973986B CN 112973986 B CN112973986 B CN 112973986B CN 201911286626 A CN201911286626 A CN 201911286626A CN 112973986 B CN112973986 B CN 112973986B
- Authority
- CN
- China
- Prior art keywords
- microfluidic
- micropore
- cavity
- silicon wafer
- liquid
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 239000007788 liquid Substances 0.000 claims abstract description 42
- 239000002245 particle Substances 0.000 claims abstract description 38
- 239000011521 glass Substances 0.000 claims abstract description 31
- 238000000926 separation method Methods 0.000 claims abstract description 13
- 230000009471 action Effects 0.000 claims abstract description 5
- XUIMIQQOPSSXEZ-UHFFFAOYSA-N Silicon Chemical compound [Si] XUIMIQQOPSSXEZ-UHFFFAOYSA-N 0.000 claims description 48
- 239000010703 silicon Substances 0.000 claims description 47
- 229910052710 silicon Inorganic materials 0.000 claims description 47
- 235000012431 wafers Nutrition 0.000 claims description 45
- 239000004205 dimethyl polysiloxane Substances 0.000 claims description 28
- 235000013870 dimethyl polysiloxane Nutrition 0.000 claims description 28
- 229920000435 poly(dimethylsiloxane) Polymers 0.000 claims description 28
- CXQXSVUQTKDNFP-UHFFFAOYSA-N octamethyltrisiloxane Chemical compound C[Si](C)(C)O[Si](C)(C)O[Si](C)(C)C CXQXSVUQTKDNFP-UHFFFAOYSA-N 0.000 claims description 26
- 238000004987 plasma desorption mass spectroscopy Methods 0.000 claims description 26
- 229920002120 photoresistant polymer Polymers 0.000 claims description 19
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 claims description 16
- 239000003795 chemical substances by application Substances 0.000 claims description 9
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 claims description 8
- 238000002156 mixing Methods 0.000 claims description 8
- 229910052757 nitrogen Inorganic materials 0.000 claims description 8
- 238000004519 manufacturing process Methods 0.000 claims description 7
- 238000005516 engineering process Methods 0.000 claims description 6
- 238000009826 distribution Methods 0.000 claims description 5
- 238000004528 spin coating Methods 0.000 claims description 5
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 4
- 238000002174 soft lithography Methods 0.000 claims description 3
- 238000004140 cleaning Methods 0.000 claims description 2
- 238000001816 cooling Methods 0.000 claims 4
- WYTGDNHDOZPMIW-RCBQFDQVSA-N alstonine Natural products C1=CC2=C3C=CC=CC3=NC2=C2N1C[C@H]1[C@H](C)OC=C(C(=O)OC)[C@H]1C2 WYTGDNHDOZPMIW-RCBQFDQVSA-N 0.000 claims 1
- 238000000861 blow drying Methods 0.000 claims 1
- 238000011010 flushing procedure Methods 0.000 claims 1
- 238000001259 photo etching Methods 0.000 claims 1
- 238000004080 punching Methods 0.000 claims 1
- 238000005507 spraying Methods 0.000 claims 1
- 210000001808 exosome Anatomy 0.000 description 23
- 239000000126 substance Substances 0.000 description 18
- 238000000034 method Methods 0.000 description 11
- 210000004027 cell Anatomy 0.000 description 8
- 238000010586 diagram Methods 0.000 description 8
- 239000000203 mixture Substances 0.000 description 7
- 230000005855 radiation Effects 0.000 description 6
- 210000004369 blood Anatomy 0.000 description 5
- 239000008280 blood Substances 0.000 description 5
- 238000000206 photolithography Methods 0.000 description 5
- 238000012545 processing Methods 0.000 description 5
- 238000012216 screening Methods 0.000 description 4
- 239000000243 solution Substances 0.000 description 4
- 210000002700 urine Anatomy 0.000 description 4
- 206010003445 Ascites Diseases 0.000 description 3
- 210000001175 cerebrospinal fluid Anatomy 0.000 description 3
- 201000010099 disease Diseases 0.000 description 3
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 3
- 230000000694 effects Effects 0.000 description 3
- 230000005284 excitation Effects 0.000 description 3
- 239000012530 fluid Substances 0.000 description 3
- 238000002032 lab-on-a-chip Methods 0.000 description 3
- LLHKCFNBLRBOGN-UHFFFAOYSA-N propylene glycol methyl ether acetate Chemical compound COCC(C)OC(C)=O LLHKCFNBLRBOGN-UHFFFAOYSA-N 0.000 description 3
- 210000003296 saliva Anatomy 0.000 description 3
- 238000001179 sorption measurement Methods 0.000 description 3
- 239000007921 spray Substances 0.000 description 3
- 238000010897 surface acoustic wave method Methods 0.000 description 3
- 210000001138 tear Anatomy 0.000 description 3
- 239000002202 Polyethylene glycol Substances 0.000 description 2
- 238000004458 analytical method Methods 0.000 description 2
- 239000011324 bead Substances 0.000 description 2
- 239000013060 biological fluid Substances 0.000 description 2
- 239000000090 biomarker Substances 0.000 description 2
- 210000001772 blood platelet Anatomy 0.000 description 2
- 230000000875 corresponding effect Effects 0.000 description 2
- 238000010790 dilution Methods 0.000 description 2
- 239000012895 dilution Substances 0.000 description 2
- 238000002955 isolation Methods 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 102000039446 nucleic acids Human genes 0.000 description 2
- 108020004707 nucleic acids Proteins 0.000 description 2
- 150000007523 nucleic acids Chemical class 0.000 description 2
- -1 polydimethylsiloxane Polymers 0.000 description 2
- 229920001223 polyethylene glycol Polymers 0.000 description 2
- 238000001556 precipitation Methods 0.000 description 2
- 238000007639 printing Methods 0.000 description 2
- 230000008569 process Effects 0.000 description 2
- 102000004169 proteins and genes Human genes 0.000 description 2
- 108090000623 proteins and genes Proteins 0.000 description 2
- 238000000746 purification Methods 0.000 description 2
- 238000011084 recovery Methods 0.000 description 2
- 210000001519 tissue Anatomy 0.000 description 2
- 238000002834 transmittance Methods 0.000 description 2
- 238000000108 ultra-filtration Methods 0.000 description 2
- 238000005199 ultracentrifugation Methods 0.000 description 2
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 1
- 238000000018 DNA microarray Methods 0.000 description 1
- 206010018910 Haemolysis Diseases 0.000 description 1
- 102000004895 Lipoproteins Human genes 0.000 description 1
- 108090001030 Lipoproteins Proteins 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 229910000676 Si alloy Inorganic materials 0.000 description 1
- 230000033115 angiogenesis Effects 0.000 description 1
- 230000001640 apoptogenic effect Effects 0.000 description 1
- 230000006907 apoptotic process Effects 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 239000012620 biological material Substances 0.000 description 1
- 239000012503 blood component Substances 0.000 description 1
- 210000001124 body fluid Anatomy 0.000 description 1
- 239000010839 body fluid Substances 0.000 description 1
- 238000005119 centrifugation Methods 0.000 description 1
- 238000004587 chromatography analysis Methods 0.000 description 1
- 238000005345 coagulation Methods 0.000 description 1
- 230000015271 coagulation Effects 0.000 description 1
- 239000011248 coating agent Substances 0.000 description 1
- 238000000576 coating method Methods 0.000 description 1
- 229910052802 copper Inorganic materials 0.000 description 1
- 239000010949 copper Substances 0.000 description 1
- 230000002596 correlated effect Effects 0.000 description 1
- 230000001419 dependent effect Effects 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 210000003743 erythrocyte Anatomy 0.000 description 1
- 238000005530 etching Methods 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 210000003722 extracellular fluid Anatomy 0.000 description 1
- 239000000284 extract Substances 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 230000008588 hemolysis Effects 0.000 description 1
- 238000000703 high-speed centrifugation Methods 0.000 description 1
- 230000028993 immune response Effects 0.000 description 1
- 239000012535 impurity Substances 0.000 description 1
- 230000028709 inflammatory response Effects 0.000 description 1
- 230000010354 integration Effects 0.000 description 1
- 210000000265 leukocyte Anatomy 0.000 description 1
- 238000011528 liquid biopsy Methods 0.000 description 1
- 238000001459 lithography Methods 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- 239000004005 microsphere Substances 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 230000003287 optical effect Effects 0.000 description 1
- 239000008188 pellet Substances 0.000 description 1
- 230000002572 peristaltic effect Effects 0.000 description 1
- 230000001766 physiological effect Effects 0.000 description 1
- 239000004848 polyfunctional curative Substances 0.000 description 1
- 229920000642 polymer Polymers 0.000 description 1
- 239000002861 polymer material Substances 0.000 description 1
- 230000029058 respiratory gaseous exchange Effects 0.000 description 1
- 238000001542 size-exclusion chromatography Methods 0.000 description 1
- 238000010561 standard procedure Methods 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- 239000000758 substrate Substances 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 230000009466 transformation Effects 0.000 description 1
- 210000004881 tumor cell Anatomy 0.000 description 1
- 238000009827 uniform distribution Methods 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
Images
Classifications
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B04—CENTRIFUGAL APPARATUS OR MACHINES FOR CARRYING-OUT PHYSICAL OR CHEMICAL PROCESSES
- B04B—CENTRIFUGES
- B04B15/00—Other accessories for centrifuges
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B04—CENTRIFUGAL APPARATUS OR MACHINES FOR CARRYING-OUT PHYSICAL OR CHEMICAL PROCESSES
- B04B—CENTRIFUGES
- B04B7/00—Elements of centrifuges
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B08—CLEANING
- B08B—CLEANING IN GENERAL; PREVENTION OF FOULING IN GENERAL
- B08B3/00—Cleaning by methods involving the use or presence of liquid or steam
- B08B3/02—Cleaning by the force of jets or sprays
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B08—CLEANING
- B08B—CLEANING IN GENERAL; PREVENTION OF FOULING IN GENERAL
- B08B3/00—Cleaning by methods involving the use or presence of liquid or steam
- B08B3/04—Cleaning involving contact with liquid
- B08B3/08—Cleaning involving contact with liquid the liquid having chemical or dissolving effect
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12M—APPARATUS FOR ENZYMOLOGY OR MICROBIOLOGY; APPARATUS FOR CULTURING MICROORGANISMS FOR PRODUCING BIOMASS, FOR GROWING CELLS OR FOR OBTAINING FERMENTATION OR METABOLIC PRODUCTS, i.e. BIOREACTORS OR FERMENTERS
- C12M23/00—Constructional details, e.g. recesses, hinges
- C12M23/02—Form or structure of the vessel
- C12M23/16—Microfluidic devices; Capillary tubes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12M—APPARATUS FOR ENZYMOLOGY OR MICROBIOLOGY; APPARATUS FOR CULTURING MICROORGANISMS FOR PRODUCING BIOMASS, FOR GROWING CELLS OR FOR OBTAINING FERMENTATION OR METABOLIC PRODUCTS, i.e. BIOREACTORS OR FERMENTERS
- C12M47/00—Means for after-treatment of the produced biomass or of the fermentation or metabolic products, e.g. storage of biomass
- C12M47/04—Cell isolation or sorting
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P70/00—Climate change mitigation technologies in the production process for final industrial or consumer products
- Y02P70/50—Manufacturing or production processes characterised by the final manufactured product
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Genetics & Genomics (AREA)
- Biomedical Technology (AREA)
- Sustainable Development (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Dispersion Chemistry (AREA)
- Clinical Laboratory Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Cell Biology (AREA)
- Molecular Biology (AREA)
- Sampling And Sample Adjustment (AREA)
- Physical Or Chemical Processes And Apparatus (AREA)
Abstract
Description
技术领域technical field
本发明涉及生物医学工程技术领域,更具体的说,特别涉及一种离心装置。The invention relates to the technical field of biomedical engineering, and more specifically relates to a centrifugal device.
背景技术Background technique
外泌体是正常细胞和肿瘤细胞都可以主动分泌的一类纳米级囊泡结构,直径约为30-150nm。外泌体广泛且稳定存在于多种临床样本中,包括血液、尿液、腹水、组织液、眼泪、唾液和脑脊液等。不同来源的外泌体所含的物质存在差异,外泌体为研究潜在的各种生物标志物提供了很好的生物学材料。外泌体拥有其母细胞的特异性蛋白,其中也含有各种核酸分子,因此,外泌体携带的各种特异性蛋白和核酸分子为疾病分析提供了丰富的可检测靶标。外泌体参与调控重要的细胞生理活动,在免疫应答、凋亡、血管生成、炎症反应、凝结过程中的作用均有报道,可以成为多种疾病的早期诊断标记物,也能作为靶向药物的载体进行疾病治疗。并且基于外泌体的肿瘤治疗方法有的已经正在临床试验阶段。目前,实现外泌体临床应用的主要障碍是缺乏快速、稳定、高效提取高纯度外泌体的标准方法。Exosomes are a type of nanoscale vesicle structure that can be actively secreted by both normal cells and tumor cells, with a diameter of about 30-150 nm. Exosomes are widely and stably present in a variety of clinical samples, including blood, urine, ascites, tissue fluid, tears, saliva, and cerebrospinal fluid. The substances contained in exosomes from different sources are different, and exosomes provide good biological materials for the study of potential various biomarkers. Exosomes possess the specific proteins of their parent cells, which also contain various nucleic acid molecules. Therefore, various specific proteins and nucleic acid molecules carried by exosomes provide abundant detectable targets for disease analysis. Exosomes participate in the regulation of important cell physiological activities, and their roles in immune response, apoptosis, angiogenesis, inflammatory response, and coagulation have all been reported. They can be used as early diagnostic markers for various diseases and can also be used as targeted drugs carrier for disease treatment. And some exosome-based tumor therapy methods are already in clinical trials. At present, the main obstacle to the clinical application of exosomes is the lack of standard methods for rapid, stable, and efficient extraction of high-purity exosomes.
随着微纳加工技术的日益成熟,微流控芯片(也称芯片实验室,Lab-on-a-Chip)发展迅速,其中微泡在微流控芯片中使用广泛,例如液体混合(Ahmed D,Lab on a Chip,2009,9(18):2738-2741)。该设备通过将气泡捕获在位于微通道内部两个层流之间的“马蹄形”结构内进行操作。腔道内单马蹄形结构浸入液体之后,形成空气-液体膜,微泡振动产生微流场用于实现液体混合。With the increasing maturity of micro-nano processing technology, microfluidic chip (also known as lab-on-a-chip, Lab-on-a-Chip) develops rapidly, in which microbubbles are widely used in microfluidic chip, such as liquid mixing (Ahmed D , Lab on a Chip, 2009, 9(18):2738-2741). The device operates by trapping air bubbles within a "horseshoe" structure located between two laminar flows inside a microchannel. After the single horseshoe-shaped structure in the cavity is immersed in the liquid, an air-liquid film is formed, and the vibration of the microbubbles generates a microflow field for liquid mixing.
通过声学操控芯片实现不同粒径分离有(Mengxi W,PNAS,201709210),这种方法由两个连续的表面声波(SAW)微流体模块的集成,该平台能够直接从未稀释的全血样品中分离外泌体。通过细胞去除模块,提取直径大于1μm的微型血液成分,包括红细胞,白细胞和血小板,以获得富含EV的样品。通过外泌体分离模块,实现了EV和凋亡小体的去除,获得了具有纯化外泌体的样品。每个模块都依赖于倾斜角声表面波场。Separation of different particle sizes is achieved by acoustically manipulating the chip (Mengxi W, PNAS, 201709210). This method consists of the integration of two continuous surface acoustic wave (SAW) microfluidic modules. This platform can be used directly in undiluted whole blood samples Isolate exosomes. Through the cell removal module, micro blood components with a diameter larger than 1 μm, including red blood cells, white blood cells and platelets, are extracted to obtain EV-enriched samples. Through the exosome isolation module, the removal of EVs and apoptotic bodies was achieved, and samples with purified exosomes were obtained. Each module is dependent on the tilt angle SAW field.
现有的外泌体纯化方法包括超速离心、尺寸排阻色谱、基于磁珠的免疫亲和捕获、基于聚乙二醇的沉淀法、超滤和微流体等方法。然而,现有的技术并不理想,限制了外泌体的临床转化和应用。超速离心是最常见的外泌体纯化方法,但它产量低(回收率:5%-25%),操作过程繁琐,耗时长(超过1天),依赖昂贵的设备。由于超高速的离心,容易导致发生溶血,影响实验结果。基于尺寸排阻色谱法成本高,回收率低,纯度低。基于免疫捕获的分离方法可以收集具有中等或高纯度的外泌体,但是受限于抗体的特异性和繁琐的操作步骤,难以标准化,不适用于处理大数量及大体积的临床样本。基于聚乙二醇沉淀法耗时,杂质多,需要生物标记,外泌体完整性差。基于超滤法易堵塞,低通量。基于微流控技术的分离方法无法解决铜梁低,操作过程复杂和重复性差的问题,难以实现实验室间结构一致性。Existing exosome purification methods include ultracentrifugation, size-exclusion chromatography, magnetic bead-based immunoaffinity capture, polyethylene glycol-based precipitation, ultrafiltration, and microfluidics. However, the existing technology is not ideal, which limits the clinical transformation and application of exosomes. Ultracentrifugation is the most common exosome purification method, but it has low yield (recovery rate: 5%-25%), cumbersome operation process, long time-consuming (more than 1 day), and relies on expensive equipment. Due to ultra-high-speed centrifugation, it is easy to cause hemolysis and affect the experimental results. Size-exclusion-based chromatography is costly, with low recovery and low purity. The isolation method based on immune capture can collect exosomes with medium or high purity, but it is limited by the specificity of antibodies and cumbersome operation steps, it is difficult to standardize, and it is not suitable for processing large quantities and large volumes of clinical samples. The polyethylene glycol-based precipitation method is time-consuming, has many impurities, requires biomarkers, and has poor integrity of exosomes. Based on the ultrafiltration method, it is easy to clog and has low throughput. The separation method based on microfluidic technology cannot solve the problems of low copper beam, complicated operation process and poor repeatability, and it is difficult to achieve structural consistency between laboratories.
发明内容Contents of the invention
本发明的目的在于针对现有技术存在的技术问题,提供一种离心装置,其结构、简单高效,并具有更高的生物安全性和更高的结果一致性,也具有自动化和高重复性,分离得到产物的结构完整。The purpose of the present invention is to solve the technical problems in the prior art, to provide a centrifugal device, which has a simple and efficient structure, and has higher biological safety and higher consistency of results, as well as automation and high repeatability. The isolated product was structurally intact.
为了解决以上提出的问题,本发明采用的技术方案为:In order to solve the problems raised above, the technical solution adopted in the present invention is:
一种离心装置,包括载玻片、信号发生器、功率放大器和换能器;所述载玻片上贴合有相互键合的微孔结构和腔道结构,并设置有所述换能器;A centrifugal device, comprising a slide glass, a signal generator, a power amplifier and a transducer; the slide glass is attached with a micropore structure and a cavity structure bonded to each other, and is provided with the transducer;
所述腔道结构用于通入待分离液体;所述信号发生器用于产生电信号,所述功率放大器用于将所述电信号进行放大,所述换能器用于将放大后的电信号转换成超声信号并作用在所述微孔结构上;所述待分离液体经过所述微孔结构,在所述超声信号作用下形成微泡并产生共振,实现待分离液体中不同颗粒的分离。The cavity structure is used to feed the liquid to be separated; the signal generator is used to generate electrical signals, the power amplifier is used to amplify the electrical signals, and the transducer is used to convert the amplified electrical signals Generate an ultrasonic signal and act on the microporous structure; the liquid to be separated passes through the microporous structure, forms microbubbles and generates resonance under the action of the ultrasonic signal, and realizes the separation of different particles in the liquid to be separated.
进一步地,所述微孔结构无缝隙贴合在所述载玻片上,所述腔道结构设置在所述微孔结构上且两者进行键合;所述载玻片、所述微孔结构和所述腔道结构三者的对应位置上分别设置有定位结构。Further, the microporous structure is seamlessly attached to the glass slide, the cavity structure is arranged on the microporous structure and the two are bonded; the glass slide, the microporous structure Positioning structures are respectively provided at positions corresponding to the three cavity structures.
进一步地,所述微孔结构包括等直径阵列的微泡结构,相邻两行所述微泡采用交错排列。Further, the microporous structure includes a microbubble structure in an array of equal diameters, and the microbubbles in two adjacent rows are arranged in a staggered manner.
进一步地,所述腔道结构包括对称结构的微流控腔道,所有所述的微流控腔道采用蛇形分布,其两端分别作为样品入口端和样品出口端。Further, the channel structure includes microfluidic channels with a symmetrical structure, all of the microfluidic channels are distributed in a serpentine shape, and the two ends of the channels are respectively used as sample inlet ports and sample outlet ports.
进一步地,所述的微泡的阵列范围大于所述微流控腔道的分布范围。Further, the array range of the microbubbles is larger than the distribution range of the microfluidic channel.
进一步地,所述微孔结构和所述腔道结构均采用PDMS芯片,并通过软光刻和模具复印技术制作得到。Further, both the microporous structure and the cavity structure are made of PDMS chips, and are manufactured by soft lithography and mold printing techniques.
进一步地,所述微孔结构和所述腔道结构的制作过程包括如下步骤:Further, the manufacturing process of the microporous structure and the channel structure includes the following steps:
步骤S1:选取两片硅片放置在纯酒精溶液中清洗,用氮气吹干,并放置在热板上烘烤冷却;Step S1: Select two silicon wafers and place them in pure alcohol solution to clean them, dry them with nitrogen, and place them on a hot plate to bake and cool;
步骤S2:将清洗烘干后的硅片放置在旋涂仪上,加入负光刻胶进行旋涂,并放置在热板上烘烤冷却;Step S2: Place the cleaned and dried silicon wafer on a spin coater, add a negative photoresist for spin coating, and place it on a hot plate to bake and cool;
步骤S3:将含有微流控腔道的菲林片和含有微孔阵列结构的菲林片分别置于所述硅片上光刻胶区域的正上方,通过光刻机对所述光刻胶区域进行曝光处理,并放置在热板上烘烤冷却;Step S3: Place the film sheet containing the microfluidic cavity and the film sheet containing the microhole array structure directly above the photoresist area on the silicon wafer, and perform photolithography on the photoresist area by a photolithography machine Exposure treatment, and placed on a hot plate to bake and cool;
步骤S4:将曝光处理后的硅片浸入SU-8显影液中,晃动玻璃皿,并采用显影液喷淋和异丙醇进行冲洗,用氮气吹干,并放置在热板上烘烤冷却,得到两片分别含有微流控腔道和微孔阵列结构的硅片;Step S4: immerse the exposed silicon wafer in the SU-8 developer, shake the glass dish, spray the developer and rinse with isopropanol, dry it with nitrogen, and place it on a hot plate to bake and cool. Obtain two silicon wafers respectively containing microfluidic cavity and microhole array structure;
步骤S5:将PDMS主剂与硬化剂按比例混合均匀得到混合剂,并将所述混合剂分别倒入所述含有微流控腔道的硅片和含有微孔阵列结构的硅片上;Step S5: mixing the PDMS main agent and the hardening agent in proportion to obtain a mixture, and pouring the mixture into the silicon wafer containing the microfluidic cavity and the silicon wafer containing the microwell array structure;
步骤S6:对所述硅片进行抽真空处理除去PDMS里面的气泡,并进行固化处理;Step S6: vacuumize the silicon wafer to remove the air bubbles in the PDMS, and perform curing treatment;
步骤S7:揭下固化后的PDMS,用打孔器在含有微流控腔道的硅片上打孔作为待测液体入口端和出口端;Step S7: peel off the cured PDMS, and use a puncher to punch holes on the silicon wafer containing the microfluidic cavity as the inlet and outlet of the liquid to be tested;
步骤S8:将两片分别含有微流控腔道和微孔阵列结构的硅片键合在一起得到PDMS微流控芯片,并贴合在所述载玻片上。Step S8: bonding two silicon wafers respectively containing the microfluidic cavity and the microwell array structure together to obtain a PDMS microfluidic chip, and attaching it to the glass slide.
进一步地,所述载玻片选用高透光医用载玻片。Further, the slides are high-transmittance medical slides.
进一步地,所述换能器采用PZT压电换能器。Further, the transducer adopts a PZT piezoelectric transducer.
与现有技术相比,本发明的有益效果在于:Compared with prior art, the beneficial effect of the present invention is:
本发明通过微孔结构和腔道结构对待分离液体直接进行分离,无需稀释,并通过信号发生器、功率放大器和换能器产生激励信号作用于微泡产生共振,进行无直接接触、无损伤的操控和筛选,并可通过调节不同功率能量,实时离心各种梯度纳米微米级别物质,具有结构简单、输入能量低、成本低、时效高等特点,也可以用自动方式在单个装置上直接从生物流体分离所需物质,分离物质纯度高、产量高且结构完整。The invention directly separates the liquid to be separated through the microporous structure and the cavity structure without dilution, and generates excitation signals through the signal generator, power amplifier and transducer to act on the microbubbles to generate resonance, so that there is no direct contact and no damage. Manipulation and screening, and real-time centrifugation of various gradient nano-micron-level substances by adjusting different power energies. It has the characteristics of simple structure, low input energy, low cost, and high timeliness. It can also be directly obtained from biological fluids on a single device in an automatic way Separation of the required substances, the isolated substances have high purity, high yield and complete structure.
附图说明Description of drawings
图1为本发明离心装置的整体结构示意图。Figure 1 is a schematic diagram of the overall structure of the centrifugal device of the present invention.
图2为本发明中载玻片的平面结构图。Fig. 2 is a plane structure diagram of a glass slide in the present invention.
图3为本发明中微孔结构的平面结构图。Fig. 3 is a plan view of the microporous structure in the present invention.
图4为本发明中腔道结构的平面结构图。Fig. 4 is a plan view of the lumen structure of the present invention.
图5为本发明中微泡结构的示意图。Fig. 5 is a schematic diagram of the microbubble structure in the present invention.
图6为本发明中阵列微泡捕获细胞概念图。Fig. 6 is a conceptual diagram of cells captured by array microbubbles in the present invention.
图7为本发明中微孔结构和腔道结构的制作流程图。Fig. 7 is a flow chart of the fabrication of the microporous structure and the cavity structure in the present invention.
图8为本发明中微孔结构和腔道结构的加工制作示意图。Fig. 8 is a schematic diagram of the fabrication of the microporous structure and the cavity structure in the present invention.
图9为本发明中PS小球在芯片工作情况下吸附释放的情况。Fig. 9 is the situation of adsorption and release of PS pellets in the chip working condition in the present invention.
图10为本发明样品出口端得到物质粒径与其含量的关系示意图。Fig. 10 is a schematic diagram of the relationship between the particle size of the material obtained at the outlet of the sample and its content in the present invention.
附图说明如下:10-载玻片、20-信号发生器、30-功率放大器、40-换能器、50-微孔结构、60-腔道结构、11、12、13、14-第一定位结构、51、52、53、54-第二定位结构、61、62、63、64-第三定位结构、501-微泡结构、601-微流控腔道。The description of the drawings is as follows: 10-slide, 20-signal generator, 30-power amplifier, 40-transducer, 50-micropore structure, 60-cavity structure, 11, 12, 13, 14-first Positioning structure, 51, 52, 53, 54-second positioning structure, 61, 62, 63, 64-third positioning structure, 501-microbubble structure, 601-microfluidic cavity.
具体实施方式Detailed ways
为了便于理解本发明,下面将参照相关附图对本发明进行更全面的描述。附图中给出了本发明的较佳实施例。但是,本发明可以以许多不同的形式来实现,并不限于本文所描述的实施例。相反地,提供这些实施例的目的是使对本发明的公开内容的理解更加透彻全面。In order to facilitate the understanding of the present invention, the present invention will be described more fully below with reference to the associated drawings. Preferred embodiments of the invention are shown in the accompanying drawings. However, the present invention can be embodied in many different forms and is not limited to the embodiments described herein. On the contrary, these embodiments are provided to make the understanding of the disclosure of the present invention more thorough and comprehensive.
除非另有定义,本文所使用的所有的技术和科学术语与属于本发明的技术领域的技术人员通常理解的含义相同。本文中在本发明的说明书中所使用的术语只是为了描述具体的实施例的目的,不是旨在于限制本发明。Unless otherwise defined, all technical and scientific terms used herein have the same meaning as commonly understood by one of ordinary skill in the technical field of the invention. The terms used herein in the description of the present invention are for the purpose of describing specific embodiments only, and are not intended to limit the present invention.
参阅图1所示,本发明实施例提供一种离心装置,包括载玻片10、信号发生器20、功率放大器30、换能器40;所述载玻片10上贴合有所述微孔结构50和腔道结构60,并设置有所述换能器40;所述微孔结构50和所述腔道结构60键合。Referring to Fig. 1, an embodiment of the present invention provides a centrifugal device, including a
所述腔道结构60用于通入待分离液体;所述信号发生器20用于产生电信号,所述功率放大器30用于将所述电信号进行放大,所述换能器40用于将放大后的电信号转换成超声信号并作用在所述微孔结构50上;所述待分离液体经过所述微孔结构50,在所述超声信号作用下形成微泡并产生共振,实现待分离液体中不同颗粒的分离。The
本发明实施例提供的离心装置中,所述腔道结构60由外部低压蠕动泵通入待分离液体后,由于存在液体表面张力,待分离液体流过所述微孔结构50之后,在超声信号的激励下,形成液体-空气膜并形成微泡,被待分离液体包围的空气和周围液体之间存在压力差,使得所形成的微泡产生稳态空化,发生共振实现待分离液体中不同颗粒的分离。由于所述微泡的共振频率取决于输入能量的大小,因此,本发明实施例中可以通过调整所述信号发生器20输入电信号的能量或者频率改变微泡的振动幅度,实现对不同粒子的捕获,并可以通过调节信号发生器20的不同幅值来改变微泡共振,实现不同纳米或微米级别粒径的分离。In the centrifuge device provided by the embodiment of the present invention, after the
本发明实施例中,所述微孔结构50无缝隙贴合在所述载玻片10上,所述腔道结构60设置在所述微孔结构50上且两者进行键合,这样超声信号能够可靠有效地作用在所述微孔结构50上。为了保证所述微孔结构50、所述腔道结构60和所述载玻片10三者能够无缝隙贴合在一起,三者的对应位置上分别设置有定位结构,参阅图2~4所示,即所述载玻片10上设置有第一定位结构(11、12、13、14),所述微孔结构50上设置有第二定位结构(51、52、53、54),所述腔道结构60上设置有第三定位结构(61、62、63、64),结构简单并可实现快速、准确键合。In the embodiment of the present invention, the
本发明实施例中,所述微孔结构50包括等直径阵列分布的微泡结构501,相邻两行所述微泡结构501交错排列(参阅图5所示),能够实现液体中物质均匀分布在所述微流控腔道内,使得其中大物质被气泡充分均匀抓捕,从而可靠地实现大规模颗粒筛选。进一步地,所述微泡结构501的直径优选为40μm,由于不同直径的微泡振动幅度是不同的,对周围环境的扰动也是不一样的,不同直径的粒子在同一微泡场中的速度也是不同的,因此可以通过改变所述微泡结构501的直径来筛选不同直径的粒子。In the embodiment of the present invention, the
本发明实施例中,所述腔道结构60包括对称结构的微流控腔道601,所有微流控腔道601采用蛇形分布,其两端分别作为样品入口端2和样品出口端8。所述微流控腔道601采用对称结构并以蛇形分布,这样通入液体时使液体能充分在所述微流控腔道601内过滤掉较大的物质,保证分离的可靠性。所述的微流控腔道601可盛放血液、尿液或其他待分离液体。In the embodiment of the present invention, the
进一步地,所述微流控腔道601的两端通过打孔器进行打孔作为样品入口端2和样品出口端8,所述待分离液体采用注射器通过软管经样品入口端1注入所述微流控腔道601内,这样可以保证整个分离过程安全可靠,也不受污染。Further, the two ends of the
本发明实施例中,所述微孔结构50上所述微泡501的阵列范围大于所述微流控腔道601的分布范围,这样便于两者进行可靠地键合。In the embodiment of the present invention, the array range of the
本发明实施例中,所述的载玻片10选用高透光医用载玻片,其效果好。In the embodiment of the present invention, the
本发明实施例中,所述换能器40采用PZT压电换能器,其能够可靠有效地将电信号转换为超声信号。In the embodiment of the present invention, the
图6为本发明阵列微泡捕获细胞概念图,其中气泡为微泡,细胞为待分离液体中的颗粒,具体为:Figure 6 is a conceptual diagram of cells captured by array microbubbles of the present invention, wherein the bubbles are microbubbles, and the cells are particles in the liquid to be separated, specifically:
所述的微流控腔道601在注入待分离液体之后,待分离液体经过阵列的所述微泡结构501时形成稳定微泡,当微泡受到波长远大于其直径的声场激励时,微泡发生振动而产生微流。通过表面膜“呼吸”作用影响周围流体介质,并将能量传递到微流控腔道601内的颗粒(即待分离物质)子上,实现颗粒的操控。所述的微流控腔道601内的颗粒在微泡的振动作用下,主要受到声辐射力和微流诱导拉拽力的作用,共振微泡产生的入射波散射而导致颗粒受到辐射力的作用,即微泡产生的力能够将待分离液体中的颗粒吸附住。所述的微流控腔道601内的颗粒与微泡的距离对声辐射力的大小影响极大,理论上,颗粒的密度大于液体的密度时,粒子被吸引。所述的微流控腔道601内颗粒的密度小于液体的密度时,被排斥。当液体密度和颗粒的密度相等时,颗粒受到的辐射力非常小。所述的微流控辐射力随着微泡直径的增加而增加,颗粒直径与辐射力也呈正相关。After the
本发明实施例中,所述的微孔结构50和所述腔道结构60均采用PDMS(聚二甲基硅氧烷:polydimethylsiloxane)芯片,并通过软光刻和模具复印技术制作得到,参阅图7所示,具体制作过程包括如下步骤:In the embodiment of the present invention, the
步骤S1:选取两片硅片放置在纯酒精溶液中清洗,用氮气吹干,并放置在热板上烘烤冷却。Step S1: Select two silicon wafers, clean them in pure alcohol solution, blow them dry with nitrogen, and place them on a hot plate to bake and cool.
步骤S2:将清洗烘干后的硅片放置在旋涂仪上,加入负光刻胶进行旋涂,并放置在热板上烘烤冷却。Step S2: Place the cleaned and dried silicon wafer on a spin coater, add a negative photoresist for spin coating, and place it on a hot plate to bake and cool.
步骤S3:将含有微流控腔道的菲林片和含有微孔阵列结构的菲林片分别置于所述硅片上光刻胶区域的正上方,通过光刻机对所述光刻胶区域进行曝光处理,并放置在热板上烘烤冷却。Step S3: Place the film sheet containing the microfluidic cavity and the film sheet containing the microhole array structure directly above the photoresist area on the silicon wafer, and perform photolithography on the photoresist area by a photolithography machine Expose and place on a hot plate to bake and cool.
步骤S4:将曝光处理后的硅片浸入SU-8显影液中,晃动玻璃皿,并用显影液喷淋冲洗残留的光刻胶,用异丙醇冲洗去除残留的显影液,用氮气吹干,并放置在热板上烘烤冷却,得到两片分别含有微流控腔道和微孔阵列结构的硅片。Step S4: immerse the exposed silicon wafer in the SU-8 developer, shake the glass dish, spray and rinse the residual photoresist with the developer, rinse with isopropanol to remove the residual developer, and blow dry with nitrogen. And placed on a hot plate to bake and cool, to obtain two silicon wafers respectively containing microfluidic cavity and microhole array structure.
步骤S5:将PDMS主剂与硬化剂按比例混合均匀得到混合剂,并将所述混合剂分别倒入所述含有微流控腔道的硅片和含有微孔阵列结构的硅片上。Step S5: mixing the PDMS main agent and the hardener in proportion to obtain a mixture, and pouring the mixture onto the silicon wafer containing the microfluidic cavity and the silicon wafer containing the microwell array structure respectively.
步骤S6:对所述硅片进行抽真空处理除去PDMS里面的气泡,并进行固化处理。Step S6: vacuumize the silicon wafer to remove air bubbles in the PDMS, and perform curing treatment.
步骤S7:揭下固化后的PDMS,用打孔器在含有微流控腔道的硅片上打孔作为待测液体入口端和出口端。Step S7: peel off the cured PDMS, and use a hole puncher to punch holes on the silicon wafer containing the microfluidic cavity as the inlet port and the outlet port of the liquid to be tested.
步骤S8:将两片分别含有微流控腔道和微孔阵列结构的硅片键合在一起得到PDMS微流控芯片,并贴合在所述载玻片1上。Step S8: bonding two silicon wafers respectively containing the microfluidic cavity and the microwell array structure together to obtain a PDMS microfluidic chip, and attaching it to the slide glass 1 .
下面通过具体实例详细说明所述微孔结构和所述微流控腔道的制作过程,参阅图8a和图8b所示,具体步骤如下:The manufacturing process of the microporous structure and the microfluidic channel will be described in detail below through specific examples, as shown in Figure 8a and Figure 8b, and the specific steps are as follows:
(1)清洗:将两片硅片放置在纯酒精溶液中清洗,并用氮气吹干;(1) Cleaning: Clean the two silicon wafers in pure alcohol solution, and dry them with nitrogen;
(2)烘干:将洁净后的硅片放在120℃的热板上烘烤30min,去除硅片上残留的水分,并冷却;(2) Drying: bake the cleaned silicon wafer on a hot plate at 120°C for 30 minutes to remove residual moisture on the silicon wafer and cool it;
(3)涂胶:将洁净烘干后的硅片放置在旋涂仪上,加入2ml负光刻胶SU-8 3025,并以500rpm旋涂15s、2000rpm旋涂30s;其中,由于所述光刻胶非常粘稠,为了提高旋涂良品率,可以根据硅片的直径选择旋涂时间,使得所述光刻胶更好地在硅片上摊开;(3) Coating: place the clean and dried silicon wafer on a spin coater, add 2ml of negative photoresist SU-8 3025, and spin coat at 500rpm for 15s and 2000rpm for 30s; The resist is very viscous. In order to improve the spin-coating yield, the spin-coating time can be selected according to the diameter of the silicon wafer, so that the photoresist can be better spread on the silicon wafer;
(4)前烘:将旋涂后的硅片放在95℃的热板上烘烤20min,并冷却至室温;(4) Pre-baking: bake the spin-coated silicon wafer on a hot plate at 95°C for 20 minutes, and cool to room temperature;
(5)曝光:分别将含有微流控腔道的菲林片和微孔阵列结构的菲林片置于硅片上光刻胶区域的正上方,通过光刻机对光刻胶区域进行曝光,设置光刻机曝光剂量为200mJ/cm2;(5) Exposure: Place the film sheet containing the microfluidic cavity and the film sheet with the microwell array structure directly above the photoresist area on the silicon wafer, and expose the photoresist area through a photolithography machine, and set The exposure dose of the lithography machine is 200mJ/cm 2 ;
(6)后烘:将曝光后的硅片放置在95℃的热板上烘烤30min,可以观察到图案逐渐显现出来;(6) Post-baking: place the exposed silicon wafer on a hot plate at 95°C and bake for 30 minutes, and the pattern can be observed to gradually appear;
(7)显影:将烘干冷却后的硅片浸入SU-8显影液中,晃动玻璃皿,使光刻胶与显影液充分接触,及时冲走松软的光刻胶,持续3min,并用显影液喷淋冲洗残留的光刻胶,用异丙醇冲洗去除残留的显影液,再用氮气吹干;(7) Development: Immerse the dried and cooled silicon wafer in the SU-8 developer, shake the glass dish, make the photoresist fully contact with the developer, wash away the soft photoresist in time, last for 3min, and use the developer Spray and rinse the residual photoresist, rinse with isopropanol to remove the residual developer, and then blow dry with nitrogen;
(8)坚膜:将硅片放在95℃的热板上烘烤30min并冷却,使光刻胶上的水分挥发之后,得到两片分别含有微流控腔道和微孔阵列结构的硅片;(8) Hardening film: put the silicon wafer on a hot plate at 95°C for 30 minutes and cool it down to volatilize the water on the photoresist to obtain two silicon wafers containing microfluidic cavity and micropore array structure respectively. piece;
(9)倒模:将PDMS主剂与硬化剂以质量比10:1的比例混合均匀,得到混合剂,并将所述混合剂分别倒入含有微流控腔道和微孔阵列结构的硅片上,抽真空15min,除去PDMS里面的气泡;(9) Inverting the mold: mix the PDMS main agent and the hardening agent evenly at a mass ratio of 10:1 to obtain a mixture, and pour the mixture into the silicon alloy containing the microfluidic cavity and the micropore array structure. On the chip, vacuumize for 15 minutes to remove the air bubbles in PDMS;
(10)固化:将两片分别含有微流控腔道和微孔阵列结构的硅片放置在80℃烤箱内烘烤1h,待PDMS完全固化;(10) Curing: Place two silicon wafers containing microfluidic cavity and micropore array structure respectively in an oven at 80°C and bake for 1 hour until the PDMS is completely cured;
(11)剥离:揭下固化后的PDMS,用孔径为0.75mm的打孔器在含有微流控腔道的硅片上的液体入口端和出口端打孔;(11) Peeling: peel off the cured PDMS, and use a hole puncher with an aperture of 0.75 mm to punch holes at the liquid inlet and outlet ports on the silicon wafer containing the microfluidic cavity;
(12)键合:将两片分别含有微流控腔道和微孔阵列结构的硅片键合在一起得到PDMS微流控芯片,PDMS微流控芯片贴合在载玻片10上。(12) Bonding: bonding two silicon wafers respectively containing the microfluidic cavity and the microwell array structure together to obtain a PDMS microfluidic chip, and the PDMS microfluidic chip is bonded on the
本发明实施例提供的所述微孔结构50和所述腔道结构60的制作方法简单、成本低廉且有效,其所采用的硅片、光刻胶和PDMS芯片均为常见的微流控芯片加工材料,成本低且方便加工。进一步地,所述PDMS芯片也可以用PLA等高分子材料代替,所述硅片也可以用其他高分子、玻璃、硅等基底代替。所述微孔结构50和所述腔道结构60也可用刻蚀等其他微纳加工工艺制作。The manufacturing method of the
图9为PS小球在PDMS微流控芯片工作情况下吸附释放的情况:其中,图a为断开电源芯片不工作情况下颗粒流动,即在没有电源的情况下,含有颗粒的待分离液体会直接流过微流控腔道601;图b为芯片工作情况颗粒被吸附,即通上电源后,微泡形成,将待分离液体中的颗粒进行捕获吸附;图c为断开电源吸附的颗粒被释放,即再次断开电源时,微泡消失,吸附的颗粒被释放。Figure 9 shows the adsorption and release of PS beads when the PDMS microfluidic chip is working: Among them, Figure a shows the flow of particles when the chip is not working when the power is turned off, that is, in the absence of power, the liquid to be separated containing particles It will flow directly through the
图10为样品出口端得到物质粒径与其含量的关系示意图,表示在PDMS微流控芯片工作后,样品出口端的物质在nanosight检测下,其物质的粒径在106nm粒径下的含量最多,横轴为物质粒径大小,纵轴是不同粒径的物质的含量,因此表明通过本发明提供的离心装置的作用,得到的物质符合外泌体的粒径分布区间。Figure 10 is a schematic diagram of the relationship between the particle size of the substance obtained at the sample outlet and its content. It shows that after the PDMS microfluidic chip works, the substance at the sample outlet is detected by nanosight, and the particle size of the substance is 106nm. The axis is the particle size of the substance, and the vertical axis is the content of substances with different particle sizes, so it shows that through the action of the centrifugal device provided by the present invention, the obtained substances conform to the particle size distribution range of exosomes.
本发明实施例提供的离心装置通过所述微孔结构50和所述腔道结构60对待分离液体进行分离,即无需稀释并可直接进行分离,耗时少,经过实验显示仅需要3小时即可收集到外泌体,收集到的外泌体浓度高,纯度高,具有成本效益。此外,通过信号发生器20、功率放大器30和换能器40产生信号进行激励,即通过外部激励微泡产生共振,从而生成微流场,利用声微流可以对腔道结构60内的生物体进行无直接接触、无损伤的操控和筛选,且可通过调节输入信号大小进而控制作用力大小,实现对不同微米纳米粒径物质进行捕获,装置结构、简单高效,无标记、无接触,最大限度地减少捕获物质的破坏,并具有更高的生物安全性和更高的结果一致性,也具有自动化和高重复性,分离得到产物的结构完整。The centrifuge device provided by the embodiment of the present invention separates the liquid to be separated through the
本发明实施例提供的离心装置可适用于生物医学、化学分析、液体活检、生物芯片技术等领域,可以在细胞、微球、微生物的富集和筛选、微流体混合上的应用,也可应用到血液、尿液、腹水、组织液、眼泪、唾液和脑脊液等生物液体的外泌体提取,并且可以通过改变能量输入,实现对不同粒径物质进行分离(脂蛋白,外泌体,血小板等)。所述离心装置的样品出口端8也可连接光学仪器样品检测机构,可用于检测血液、也可以检测尿液、腹水、组织液、眼泪、唾液和脑脊液等其他体液。The centrifugal device provided by the embodiment of the present invention can be applied to the fields of biomedicine, chemical analysis, liquid biopsy, biochip technology, etc. It can be used in the enrichment and screening of cells, microspheres, microorganisms, and microfluidic mixing. Extract exosomes from biological fluids such as blood, urine, ascites, tissue fluid, tears, saliva, and cerebrospinal fluid, and can separate substances of different particle sizes (lipoproteins, exosomes, platelets, etc.) by changing the energy input . The
上述实施例为本发明较佳的实施方式,但本发明的实施方式并不受上述实施例的限制,其他的任何未背离本发明的精神实质与原理下所作的改变、修饰、替代、组合、简化,均应为等效的置换方式,都包含在本发明的保护范围之内。The above-mentioned embodiment is a preferred embodiment of the present invention, but the embodiment of the present invention is not limited by the above-mentioned embodiment, and any other changes, modifications, substitutions, combinations, Simplifications should be equivalent replacement methods, and all are included in the protection scope of the present invention.
Claims (7)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201911286626.2A CN112973986B (en) | 2019-12-14 | 2019-12-14 | a centrifugal device |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201911286626.2A CN112973986B (en) | 2019-12-14 | 2019-12-14 | a centrifugal device |
Publications (2)
Publication Number | Publication Date |
---|---|
CN112973986A CN112973986A (en) | 2021-06-18 |
CN112973986B true CN112973986B (en) | 2023-07-14 |
Family
ID=76342586
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201911286626.2A Active CN112973986B (en) | 2019-12-14 | 2019-12-14 | a centrifugal device |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN112973986B (en) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2023019431A1 (en) * | 2021-08-17 | 2023-02-23 | 深圳高性能医疗器械国家研究院有限公司 | Device and method for stimulating secretion of cellular exosomes, and obtained exosomes and application thereof |
Family Cites Families (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU2002364937A1 (en) * | 2001-10-18 | 2003-06-17 | The Board Of Trustees Of The University Of Illinois | Hybrid microfluidic and nanofluidic system |
CN101561446A (en) * | 2009-06-04 | 2009-10-21 | 大连理工大学 | Glass micro-nano-fluidic control chip, preparation and assembly method and auxiliary assembly device thereof |
CN102240534B (en) * | 2011-05-20 | 2014-06-25 | 中国科学院化学研究所 | Method for manufacturing three-dimensional micromixer microfluidic chip |
CN104195028B (en) * | 2014-08-05 | 2017-07-25 | 深圳先进技术研究院 | Microfluidic chip and cell screening method for screening specific cells |
CN108239661B (en) * | 2016-12-23 | 2020-06-12 | 中国科学院深圳先进技术研究院 | Microfluidic device, system and method for introducing substance into cell |
CN109012771B (en) * | 2018-07-23 | 2020-06-09 | 武汉大学 | Full-transparent microfluidic acoustic bulk wave chip and preparation method thereof |
CN109540771B (en) * | 2018-12-18 | 2020-12-08 | 武汉大学 | An acousto-optic microfluidic chip for precise sorting of leukocyte subtypes and a sorting method thereof |
CN209612920U (en) * | 2018-12-27 | 2019-11-12 | 苏州纳葛诺斯生物科技有限公司 | Micro-and nano-particles highly effective reaction micro-fluidic chip based on surface acoustic wave |
CN109482121B (en) * | 2018-12-27 | 2024-02-23 | 苏州纳葛诺斯生物科技有限公司 | Micro-nano particle high-efficiency reaction micro-fluidic chip based on surface acoustic wave |
CN110004043B (en) * | 2019-04-09 | 2020-11-03 | 东北大学 | Single cell capture micro-fluidic chip |
CN110237873B (en) * | 2019-04-28 | 2024-05-07 | 杭州电子科技大学 | Sheath-flow-free micro-fluidic chip for particle separation based on surface acoustic wave |
-
2019
- 2019-12-14 CN CN201911286626.2A patent/CN112973986B/en active Active
Also Published As
Publication number | Publication date |
---|---|
CN112973986A (en) | 2021-06-18 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN110004043B (en) | Single cell capture micro-fluidic chip | |
CN110496655B (en) | A tumor cell detection chip based on microfluidic technology | |
CN112076808B (en) | Method and apparatus for controlling movement of particles in solution using ultra-high frequency sound waves | |
CN107118938B (en) | Fluid enhances the unicellular arrangement of dielectrophoresis and control chip and preparation method thereof | |
JP5920895B2 (en) | Method and device for isolating cells from heterogeneous solutions using microfluidic capture vortices | |
CN111334403A (en) | Micro-bubble generation chip based on micro-fluidic and preparation method and application thereof | |
US20110301058A1 (en) | microfluidic device | |
JP2010193891A (en) | Detection, separation or isolation of target molecule, using microchannel apparatus | |
JP2010075191A (en) | Microfluidic device for cell separation and use thereof | |
CN110314715A (en) | Micro-fluidic chip is enriched with based on focusing surface acoustic wave and the particle of microlayer model technology | |
Liu et al. | Rapid cell pairing and fusion based on oscillating bubbles within an acoustofluidic device | |
CN112973986B (en) | a centrifugal device | |
CN106914288A (en) | A kind of micro-fluidic high frequency sound focusing chip and preparation method thereof | |
CN106345543B (en) | A kind of microring array chip of the charge inducing electric osmose based on fixed potential | |
Yadhuraj et al. | Design and Development of Micro-channel using PDMS for Biomedical Applications | |
CN115970775B (en) | Centrifugal-driven micro-fluidic chip, preparation method and application | |
CN103278643B (en) | Preparation method of microchip for microprotein detection | |
CN114308151B (en) | Acoustic microfluidic system for cell fusion and preparation method and application thereof | |
JP2015149986A (en) | Microchannel for capturing cells | |
WO2023093404A1 (en) | Microparticle self-entrainment type microfluidic chip and manufacturing method therefor, and microparticle self-dispersion method | |
WO2023102818A1 (en) | Acoustic microfluidic system for cell fusion and preparation method therefor and application thereof | |
Mizoi et al. | Deformation of Cell Passing through Micro Slit between Micro Ridges | |
CN110787847B (en) | A DEP-based particle liquid exchange method and device | |
Rodriguez | Rare Cell Trapping Using Microfluidics Platform With Integrated Micro-Vortex and Size Exclusion Features | |
Ahasan | Characterization of high-Reynolds deterministic lateral displacement in terms of angle of attack of the airfoil shaped pillar |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant |